MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Primary Central Nervous System Lymphoma

  1. Home
  2. Diseases
  3. Primary Central Nervous System Lymphoma
  4. Clinical Trials

Clinical Trials Related to Primary Central Nervous System Lymphoma

Related studies linked through entity extraction aliases.

NCT00863460

Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young Patients

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE2

NCT00712062

Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System Lymphoma

Status
WITHDRAWN
Phase
PHASE2

NCT00455286

a Phase II Study in Primary Central Nervous System Lymphoma

Status
UNKNOWN
Phase
PHASE2

NCT00193973

Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma

Status
COMPLETED
Phase
PHASE2

NCT00112593

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer

Status
COMPLETED
Phase
NA

NCT00003505

Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Status
WITHDRAWN
Phase
PHASE2
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.